Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells.

Davis DA, Shrestha P, Aisabor AI, Stream A, Galli V, Pise-Masison CA, Tagawa T, Ziegelbauer JM, Franchini G, Yarchoan R.

Oncoimmunology. 2018 Dec 5;8(2):e1546544. doi: 10.1080/2162402X.2018.1546544. eCollection 2019.

2.

Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.

Sharma VK, Raimondi V, Ruggero K, Pise-Masison CA, Cavallari I, Silic-Benussi M, Ciminale V, D'Agostino DM.

Front Microbiol. 2018 May 4;9:832. doi: 10.3389/fmicb.2018.00832. eCollection 2018.

3.

Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.

Barreto FK, Khouri R, Rego FFA, Santos LA, Castro-Amarante MF, Bialuk I, Pise-Masison CA, Galvão-Castro B, Gessain A, Jacobson S, Franchini G, Alcantara LC Jr.

Infect Genet Evol. 2016 Nov;45:420-425. doi: 10.1016/j.meegid.2016.08.020. Epub 2016 Aug 21.

4.

Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.

de Castro-Amarante MF, Pise-Masison CA, McKinnon K, Washington Parks R, Galli V, Omsland M, Andresen V, Massoud R, Brunetto G, Caruso B, Venzon D, Jacobson S, Franchini G.

J Virol. 2015 Nov 25;90(5):2195-207. doi: 10.1128/JVI.02735-15.

5.

Transcription profiling of CD4⁺ T cells in rhesus macaques that infected with simian-human immunodeficiency virus and re-challenged with SIVmac251.

Chung HK, Pise-Masison CA, Muthiah A, Radonovich MF, Lee EM, Lee JK, Pal R.

J Med Primatol. 2015 Oct;44(5):263-74. doi: 10.1111/jmp.12185. Epub 2015 Aug 31.

PMID:
26332118
6.

The Tax oncogene enhances ELL incorporation into p300 and P-TEFb containing protein complexes to activate transcription.

Fufa TD, Byun JS, Wakano C, Fernandez AG, Pise-Masison CA, Gardner K.

Biochem Biophys Res Commun. 2015 Sep 11;465(1):5-11. doi: 10.1016/j.bbrc.2015.07.072. Epub 2015 Jul 17.

PMID:
26188510
7.

Co-dependence of HTLV-1 p12 and p8 functions in virus persistence.

Pise-Masison CA, de Castro-Amarante MF, Enose-Akahata Y, Buchmann RC, Fenizia C, Washington Parks R, Edwards D, Fiocchi M, Alcantara LC Jr, Bialuk I, Graham J, Walser JC, McKinnon K, Galvão-Castro B, Gessain A, Venzon D, Jacobson S, Franchini G.

PLoS Pathog. 2014 Nov 6;10(11):e1004454. doi: 10.1371/journal.ppat.1004454. eCollection 2014 Nov.

8.

Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.

Ju W, Zhang M, Petrus M, Maeda M, Pise-Masison CA, Waldmann TA.

Retrovirology. 2014 Jun 2;11:43. doi: 10.1186/1742-4690-11-43.

9.

Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission.

Chevalier SA, Turpin J, Cachat A, Afonso PV, Gessain A, Brady JN, Pise-Masison CA, Mahieux R.

PLoS Pathog. 2014 Feb 27;10(2):e1003917. doi: 10.1371/journal.ppat.1003917. eCollection 2014 Feb.

10.

Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Liyanage NP, Gordon SN, Doster MN, Pegu P, Vaccari M, Shukur N, Schifanella L, Pise-Masison CA, Lipinska D, Grubczak K, Moniuszko M, Franchini G.

Virology. 2014 Feb;450-451:359-68. doi: 10.1016/j.virol.2013.12.003. Epub 2014 Jan 21.

11.

Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, Chevalier SA, Edwards D, Ruscetti F, Pise-Masison CA, Franchini G.

J Virol. 2014 Jan;88(1):393-402. doi: 10.1128/JVI.01788-13. Epub 2013 Oct 23.

12.

Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.

Chen J, Pise-Masison CA, Shih JH, Morris JC, Janik JE, Conlon KC, Keating A, Waldmann TA.

Blood. 2013 Mar 14;121(11):2029-37. doi: 10.1182/blood-2012-05-427773. Epub 2013 Jan 15.

13.

The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.

Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN, Mahieux R, Pise-Masison CA.

PLoS One. 2012;7(7):e41003. doi: 10.1371/journal.pone.0041003. Epub 2012 Jul 20.

14.

Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.

Edwards DC, McKinnon KM, Fenizia C, Jung KJ, Brady JN, Pise-Masison CA.

Viruses. 2011 Oct;3(10):1815-35. doi: 10.3390/v3101815. Epub 2011 Oct 10.

15.

Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.

Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G.

Viruses. 2011 Jun;3(6):861-85. doi: 10.3390/v3060861. Epub 2011 Jun 17. Review.

16.

Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Andresen V, Pise-Masison CA, Sinha-Datta U, Bellon M, Valeri V, Washington Parks R, Cecchinato V, Fukumoto R, Nicot C, Franchini G.

Blood. 2011 Aug 11;118(6):1549-59. doi: 10.1182/blood-2010-06-293340. Epub 2011 Jun 15.

17.

Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.

Cho WK, Jang MK, Huang K, Pise-Masison CA, Brady JN.

J Virol. 2010 Dec;84(24):12801-9. doi: 10.1128/JVI.00943-10. Epub 2010 Oct 6.

18.

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, Ozbun L, Samimi G, Brady J, Randonovich M, Pise-Masison CA, Barrett JC, Wong WH, Welch WR, Berkowitz RS, Birrer MJ.

Cancer Cell. 2009 Dec 8;16(6):521-32. doi: 10.1016/j.ccr.2009.10.018.

19.

Memories of John N. Brady: scientist, mentor and friend.

Pise-Masison CA, Marriott SJ.

Retrovirology. 2009 May 19;6:48. doi: 10.1186/1742-4690-6-48.

20.

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.

Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN.

Blood. 2009 Apr 23;113(17):4016-26. doi: 10.1182/blood-2008-08-175901. Epub 2009 Jan 8.

21.

Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.

Chung HK, Pise-Masison CA, Radonovich MF, Brady J, Lee JK, Cheon SY, Markham P, Cristillo A, Pal R.

Viral Immunol. 2008 Dec;21(4):411-23. doi: 10.1089/vim.2008.0076.

22.

Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.

Sakakibara S, Pise-Masison CA, Brady JN, Tosato G.

J Virol. 2009 Mar;83(5):2140-53. doi: 10.1128/JVI.01871-08. Epub 2008 Dec 17.

23.

Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.

Zhou M, Huang K, Jung KJ, Cho WK, Klase Z, Kashanchi F, Pise-Masison CA, Brady JN.

J Virol. 2009 Jan;83(2):1036-44. doi: 10.1128/JVI.01316-08. Epub 2008 Oct 29.

24.

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC, Boyd J, Birrer MJ.

Cancer Res. 2008 Jul 1;68(13):5478-86. doi: 10.1158/0008-5472.CAN-07-6595.

25.

Exenatide blocks JAK1-STAT1 in pancreatic beta cells.

Couto FM, Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Hanson M, Fernandez LA, Wang P, Kendziorski C, Shalev A.

Metabolism. 2007 Jul;56(7):915-8.

PMID:
17570252
26.

Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice.

Welch KD, Reilly TP, Bourdi M, Hays T, Pise-Masison CA, Radonovich MF, Brady JN, Dix DJ, Pohl LR.

Chem Res Toxicol. 2006 Feb;19(2):223-33.

PMID:
16485898
27.

Characterization and isolation of stem cell-enriched human hair follicle bulge cells.

Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC.

J Clin Invest. 2006 Jan;116(1):249-60.

28.

Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein.

Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Wang P, Kendziorski C, Shalev A.

Biochem Biophys Res Commun. 2005 Oct 28;336(3):770-8.

PMID:
16143294
29.

Human T cell leukemia virus type 1: the role of Tax in leukemogenesis.

Pise-Masison CA, Jeong SJ, Brady JN.

Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):283-96. Review.

PMID:
16088313
30.

Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.

Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN.

Oncogene. 2005 Oct 6;24(44):6719-28.

PMID:
16007163
31.

Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes.

Kovanen PE, Young L, Al-Shami A, Rovella V, Pise-Masison CA, Radonovich MF, Powell J, Fu J, Brady JN, Munson PJ, Leonard WJ.

Int Immunol. 2005 Aug;17(8):1009-21. Epub 2005 Jun 24.

PMID:
15980098
32.

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ.

J Exp Med. 2005 Jan 3;201(1):139-48.

33.

A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.

Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN.

J Biol Chem. 2005 Mar 18;280(11):10326-32. Epub 2004 Dec 20.

34.

Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function.

Pise-Masison CA, Brady JN.

Front Biosci. 2005 Jan 1;10:919-30. Print 2005 Jan 1. Review.

PMID:
15569630
35.

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.

Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC, Birrer MJ.

Oncogene. 2004 Oct 21;23(49):8065-77.

PMID:
15361855
36.

Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.

Lu H, Pise-Masison CA, Linton R, Park HU, Schiltz RL, Sartorelli V, Brady JN.

J Virol. 2004 Jul;78(13):6735-43.

37.

HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.

Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA.

Blood. 2004 Sep 1;104(5):1490-7. Epub 2004 May 20. Erratum in: Blood. 2007 Jan 15;109(2):411.

PMID:
15155458
38.

Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.

Kelly JA, Spolski R, Kovanen PE, Suzuki T, Bollenbacher J, Pise-Masison CA, Radonovich MF, Lee S, Jenkins NA, Copeland NG, Morse HC 3rd, Leonard WJ.

J Exp Med. 2003 Jul 7;198(1):79-89. Epub 2003 Jun 30.

39.

IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.

Xue HH, Kovanen PE, Pise-Masison CA, Berg M, Radovich MF, Brady JN, Leonard WJ.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13759-64. Epub 2002 Sep 27.

40.

Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway.

Shalev A, Pise-Masison CA, Radonovich M, Hoffmann SC, Hirshberg B, Brady JN, Harlan DM.

Endocrinology. 2002 Sep;143(9):3695-8.

PMID:
12193586
41.

Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.

Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN.

Cancer Res. 2002 Jun 15;62(12):3562-71.

42.

Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template.

Lu H, Pise-Masison CA, Fletcher TM, Schiltz RL, Nagaich AK, Radonovich M, Hager G, Cole PA, Brady JN.

Mol Cell Biol. 2002 Jul;22(13):4450-62.

43.

A protective role for cyclooxygenase-2 in drug-induced liver injury in mice.

Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR.

Chem Res Toxicol. 2001 Dec;14(12):1620-8.

PMID:
11743745
44.

Saccharomyces cerevisiae protein Pci8p and human protein eIF3e/Int-6 interact with the eIF3 core complex by binding to cognate eIF3b subunits.

Shalev A, Valásek L, Pise-Masison CA, Radonovich M, Phan L, Clayton J, He H, Brady JN, Hinnebusch AG, Asano K.

J Biol Chem. 2001 Sep 14;276(37):34948-57. Epub 2001 Jul 16.

45.

Expression profiling of acetaminophen liver toxicity in mice using microarray technology.

Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, Pohl LR.

Biochem Biophys Res Commun. 2001 Mar 23;282(1):321-8. Erratum in: Biochem Biophys Res Commun 2001 May 4;283(2):536.

PMID:
11264010
46.

Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators.

Mahieux R, Pise-Masison CA, Nicot C, Green P, Hall WW, Brady JN.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1677-81.

PMID:
11080809
47.

Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.

Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C, Brady JN.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1669-75. Review.

PMID:
11080808
48.

Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.

Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Brady JN.

J Biol Chem. 2001 Jan 5;276(1):200-5.

49.

Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Mahieux R, Pise-Masison CA, Lambert PF, Nicot C, De Marchis L, Gessain A, Green P, Hall W, Brady JN.

J Virol. 2000 Aug;74(15):6866-74.

50.

Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C, Brady JN.

Mol Cell Biol. 2000 May;20(10):3377-86.

Supplemental Content

Loading ...
Support Center